These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14978972)

  • 21. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
    Cho ML; Jung YO; Moon YM; Min SY; Yoon CH; Lee SH; Park SH; Cho CS; Jue DM; Kim HY
    Immunol Lett; 2006 Mar; 103(2):159-66. PubMed ID: 16368150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased susceptibility to tumor necrosis factor-alpha in butyric acid-induced apoptosis is caused by downregulation of cFLIP expression in Jurkat T cells.
    Seto S; Kurita-Ochiai T; Ochiai K
    Microbiol Immunol; 2008 Mar; 52(3):188-96. PubMed ID: 18402601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
    J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands.
    Ospelt C; Kurowska-Stolarska M; Neidhart M; Michel BA; Gay RE; Laufer S; Gay S
    Ann Rheum Dis; 2008 Apr; 67(4):524-9. PubMed ID: 17666446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1 beta and tumor necrosis factor.
    Taberner M; Scott KF; Weininger L; Mackay CR; Rolph MS
    Inflamm Res; 2005 Jan; 54(1):10-6. PubMed ID: 15723199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist.
    Kelso EB; Ferrell WR; Lockhart JC; Elias-Jones I; Hembrough T; Dunning L; Gracie JA; McInnes IB
    Arthritis Rheum; 2007 Mar; 56(3):765-71. PubMed ID: 17328048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory cytokine regulation of transgene expression in human fibroblast-like synoviocytes infected with adeno-associated virus.
    Traister RS; Fabre S; Wang Z; Xiao X; Hirsch R
    Arthritis Rheum; 2006 Jul; 54(7):2119-26. PubMed ID: 16802345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mu-calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line.
    Morita M; Banno Y; Dohjima T; Nozawa S; Fushimi K; Fan DG; Ohno T; Miyazawa K; Liu N; Shimizu K
    Biochem Biophys Res Commun; 2006 May; 343(3):937-42. PubMed ID: 16574073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
    Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
    Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
    Catrina AI; Klareskog L
    Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
    [No Abstract]   [Full Text] [Related]  

  • 38. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.
    Cinelli M; Guiducci S; Del Rosso A; Pignone A; Del Rosso M; Fibbi G; Serratì S; Gabrielli A; Giacomelli R; Piccardi N; Matucci Cerinic M
    Scand J Rheumatol; 2006; 35(5):346-50. PubMed ID: 17062432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes.
    Yamaura M; Yao M; Yaroslavsky I; Cohen R; Smotrich M; Kochevar IE
    Lasers Surg Med; 2009 Apr; 41(4):282-90. PubMed ID: 19347944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of synovial cell clones isolated from rheumatoid arthritis patients: possible involvement of TNF-alpha in reduction of osteoprotegerin in synovium.
    Zhao B; Takami M; Miyamoto Y; Suzawa T; Yamada A; Mochizuki A; Yasuhara R; Wang X; Inoue T; Namiki O; Sakamoto K; Kamijo R
    Cytokine; 2008 Jan; 41(1):61-70. PubMed ID: 18083042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.